{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:20:31Z","timestamp":1783124431936,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018571","name":"Specific Research Project of Guangxi for Research Bases and Talents","doi-asserted-by":"publisher","award":["GuikeAD20297053"],"award-info":[{"award-number":["GuikeAD20297053"]}],"id":[{"id":"10.13039\/501100018571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560571"],"award-info":[{"award-number":["82560571"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160447"],"award-info":[{"award-number":["82160447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011827","name":"Guangxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2020GXNSFAA297265"],"award-info":[{"award-number":["2020GXNSFAA297265"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2024GXNSFAA010011"],"award-info":[{"award-number":["2024GXNSFAA010011"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neo.2026.101324","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:04:22Z","timestamp":1780974262000},"page":"101324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the ELF1\/EGFR\/ERK positive feedback loop overcomes resistance to androgen receptor inhibition in AR-Vs positive prostate cancer"],"prefix":"10.1016","volume":"78","author":[{"given":"Menghan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-3756","authenticated-orcid":false,"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2026.101324_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.neo.2026.101324_bib0002","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: a review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.neo.2026.101324_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.37272","article-title":"Survival outcomes by race and ethnicity in veterans with nonmetastatic castration-resistant prostate cancer","volume":"6","author":"Rasmussen","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neo.2026.101324_bib0004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41585-025-01042-6","article-title":"Synergistic targeting strategies for prostate cancer","volume":"22","author":"Li","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.neo.2026.101324_bib0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"10.1016\/j.neo.2026.101324_bib0006","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101324_bib0007","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101324_bib0008","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa2003892","article-title":"Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer","volume":"382","author":"Sternberg","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101324_bib0009","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1200\/JCO-24-01798","article-title":"Darolutamide in combination with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer from the phase iii aranote trial","volume":"42","author":"Saad","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2026.101324_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0011","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1158\/1078-0432.CCR-14-1108","article-title":"Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth","volume":"21","author":"Yamamoto","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neo.2026.101324_bib0013","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neo.2026.101324_bib0014","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1158\/2159-8290.CD-13-0226","article-title":"A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509","volume":"3","author":"Joseph","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2026.101324_bib0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2159-8290.CD-13-0142","article-title":"An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)","volume":"3","author":"Korpal","year":"2013","journal-title":"Cancer Discov."},{"key":"10.1016\/j.neo.2026.101324_bib0016","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101324_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/cancers9060067","article-title":"Androgen receptor-dependent and -independent mechanisms involved in prostate cancer therapy resistance","volume":"9","author":"Crona","year":"2017","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2026.101324_bib0018","doi-asserted-by":"crossref","first-page":"312re310","DOI":"10.1126\/scitranslmed.aac9511","article-title":"Plasma AR and abiraterone-resistant prostate cancer","volume":"7","author":"Romanel","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neo.2026.101324_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/0008-5472.CAN-08-2764","article-title":"Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer","volume":"69","author":"Hu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0020","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"Sun","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101324_bib0021","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1158\/0008-5472.CAN-15-0381","article-title":"Androgen receptor splice variants dimerize to transactivate target genes","volume":"75","author":"Xu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0022","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJMra0707704","article-title":"EGFR antagonists in cancer treatment","volume":"358","author":"Ciardiello","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2026.101324_bib0023","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/annonc\/mdh257","article-title":"Pharmacological background of EGFR targeting","volume":"15","author":"Castillo","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2026.101324_bib0024","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdz141","article-title":"EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer","volume":"30","author":"Hastings","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2026.101324_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/annonc\/mdh011","article-title":"Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer","volume":"15","author":"Selvaggi","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.neo.2026.101324_bib0026","first-page":"3438","article-title":"Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer","volume":"8","author":"Di Lorenzo","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0027","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/s41416-020-01052-8","article-title":"EGFR as a stable marker of prostate cancer dissemination to bones","volume":"123","author":"Nastaly","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neo.2026.101324_bib0028","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-6-76","article-title":"Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel","volume":"6","author":"Uysal-Onganer","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.neo.2026.101324_bib0029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2020.05.027","article-title":"Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer","volume":"488","author":"Wang","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101324_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215984","article-title":"Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma","volume":"552","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101324_bib0031","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neo.2026.101324_bib0032","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41421-025-00777-1","article-title":"A basigin antibody modulates MCTs to impact tumor metabolism and immunity","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.neo.2026.101324_bib0033","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.eururo.2007.01.096","article-title":"Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells","volume":"52","author":"Paju","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neo.2026.101324_bib0034","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/0008-5472.CAN-05-3025","article-title":"Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer","volume":"66","author":"Zhang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0035","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neo.2026.101324_bib0036","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1158\/1078-0432.CCR-18-1229","article-title":"The proteome of prostate cancer bone metastasis reveals heterogeneity with prognostic implications","volume":"24","author":"Iglesias-Gato","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0037","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/cancers12051268","article-title":"Proteomic tissue-based classifier for early prediction of prostate cancer progression","volume":"12","author":"Gao","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.neo.2026.101324_bib0038","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1158\/1078-0432.CCR-07-1257","article-title":"Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer","volume":"13","author":"Schlomm","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0039","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pros.23325","article-title":"Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naive Prostate Cancer","volume":"77","author":"Josefsson","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.neo.2026.101324_bib0040","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ctrv.2015.08.002","article-title":"Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer","volume":"41","author":"Buttigliero","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.neo.2026.101324_bib0041","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","article-title":"HER2 and EGFR Overexpression support metastatic progression of prostate cancer to bone","volume":"77","author":"Day","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0042","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1158\/0008-5472.CAN-24-4855","article-title":"Extracellular domain shedding of TROP2 activates EGFR signaling to drive prostate cancer metastasis","volume":"85","author":"Liu","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2026.101324_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215994","article-title":"UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways","volume":"553","author":"Lacombe","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101324_bib0044","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00018-022-04320-3","article-title":"FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation","volume":"79","author":"Zhou","year":"2022","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neo.2026.101324_bib0045","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/acschemneuro.1c00070","article-title":"ELF1 transcription factor enhances the progression of glioma via ATF5 promoter","volume":"12","author":"Hu","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neo.2026.101324_bib0046","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1021\/acs.chemrestox.2c00233","article-title":"Transcription factor ELF1 modulates cisplatin sensitivity in prostate cancer by targeting MEIS homeobox 2","volume":"36","author":"Han","year":"2023","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neo.2026.101324_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101047","article-title":"PLXNA1 confers enzalutamide resistance in prostate cancer via AKT signaling pathway","volume":"57","author":"Hu","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2026.101324_bib0048","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/1535-7163.MCT-19-0936","article-title":"Targeting the PI3K\/AKT pathway overcomes enzalutamide resistance by inhibiting induction of the glucocorticoid receptor","volume":"19","author":"Adelaiye-Ogala","year":"2020","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.neo.2026.101324_bib0049","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","article-title":"The genome sequence archive family: toward explosive data growth and diverse data types","volume":"19","author":"Chen","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.neo.2026.101324_bib0050","doi-asserted-by":"crossref","first-page":"D27","DOI":"10.1093\/nar\/gkab951","article-title":"Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022","volume":"50","author":"Members","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neo.2026.101324_bib0051","doi-asserted-by":"crossref","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","article-title":"iProX in 2021: connecting proteomics data sharing with big data","volume":"50","author":"Chen","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:44:38Z","timestamp":1783122278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"alternative-id":["S1476558626000540"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101324","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the ELF1\/EGFR\/ERK positive feedback loop overcomes resistance to androgen receptor inhibition in AR-Vs positive prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101324"}}